EXETER, N.H.--(BUSINESS WIRE)-- Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm”), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, announced the pricing of its initial public offering of 4,000,000 shares of common stock at a price to the public of $14.00 per share. In addition, Vapotherm has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock, at the initial public offering price less underwriting discounts and commissions. The shares are expected to begin trading on the New York Stock Exchange (“NYSE”) under the ticker symbol “VAPO” on November 14, 2018.
San Francisco, CA – October 11, 2018 — Anaplan, Inc., a pioneer in Connected Planning, today announced the pricing of its initial public offering of 15,500,000 shares of its common stock at a price to the public of $17.00 per share. The shares are expected to begin trading on the New York Stock Exchange on October 12, 2018 under the ticker symbol “PLAN.” The offering is expected to close on October 16, 2018, subject to customary closing conditions.